An open-label study to evaluate a single-dose of cinacalcet in pediatric dialysis subjects

被引:0
|
作者
Desmond Padhi
Craig B. Langman
Sahar Fathallah-Shaykh
Bradley A. Warady
Isidro B. Salusky
Edward Lee
Christine Wang
Edward Posvar
机构
[1] Amgen Inc.,Early Development
[2] Northwestern University,Feinberg School of Medicine, Children’s Memorial Hospital
[3] University of Alabama at Birmingham,Division of Pediatric Nephrology
[4] University of Missouri–Kansas City School of Medicine,Children’s Mercy Hospitals and Clinics
[5] David Geffen School of Medicine at UCLA,Division of Pediatric Nephrology, Department of Pediatrics
[6] Amgen Inc.,Metabolic Disorders
来源
Pediatric Nephrology | 2012年 / 27卷
关键词
Hyperparathyroidism; CKD–MBD; Hemodialysis; End-stage renal disease; Pharmacokinetics; Pharmacodynamics; Secondary;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1953 / 1959
页数:6
相关论文
共 50 条
  • [31] Phase 1, randomized, open-label, single-dose, crossover study to evaluate the bio-equivalence of four formulations of oral rivoceranib tablets in healthy subjects.
    Weyer, Janelle
    Meng, Xianzhang
    Finis, Lynda
    Strickland, Bill
    Park, CheolHee
    Jang, Seong
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [32] Pharmacokinetics of serelaxin in patients with hepatic impairment: a single-dose, open-label, parallel group study
    Kobalava, Zhanna
    Villevalde, Svetlana
    Kotovskaya, Yulia
    Hinrichsen, Holger
    Petersen-Sylla, Marc
    Zaehringer, Andreas
    Pang, Yinuo
    Rajman, Iris
    Canadi, Jasna
    Dahlke, Marion
    Lloyd, Peter
    Halabi, Atef
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 79 (06) : 937 - 945
  • [33] A prospective, open-label study of single-dose ciprofloxacin absorption after chemotherapy in patients with malignancy
    Gattis, WA
    Petros, WP
    Pickard, WW
    Drew, RH
    May, DB
    Hathorn, JW
    PHARMACOTHERAPY, 1997, 17 (04): : 836 - 840
  • [34] An Open-Label, Single-Dose, Human Mass Balance Study of Amenamevir in Healthy Male Adults
    Kato, Kota
    den Adel, Martin
    Groenendaal-van de Meent, Dorien
    Ohtsu, Yoshiaki
    Takada, Akitsugu
    Katashima, Masataka
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2019, 8 (05): : 595 - 602
  • [35] Effect of renal function on the pharmacokinetics of fimasartan: a single-dose, open-label, Phase I study
    Kim, Seokuee
    Lee, Jongtae
    Shin, Donghoon
    Lim, Kyoung Soo
    Kim, Yon Su
    Jang, In-Jin
    Yu, Kyung-Sang
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2014, 8 : 1723 - 1731
  • [36] A Phase 1, Open-Label, Single-Dose Pharmacokinetic Study of Lasmiditan in Paediatric Patients with Migraine
    Tsai, Max
    Nery, Emel Serap Monkul
    Kerr, Lisa
    Khanna, Rashna
    Komori, Mika
    Dennehy, Ellen
    Wilbraham, Darren
    NEUROLOGY, 2021, 96 (15)
  • [37] A PHASE 1, OPEN-LABEL, SINGLE-DOSE PHARMACOKINETIC STUDY OF LASMIDITAN IN PAEDIATRIC PATIENTS WITH MIGRAINE
    Tsai, Max
    Nery, Emel Serap Monkul
    Kerr, Lisa
    Khanna, Rashna
    Komori, Mika
    Dennehy, Ellen B.
    Wilbraham, Darren
    CEPHALALGIA, 2020, 40 : 41 - 42
  • [38] Effect of renal impairment on the pharmacokinetics of prucalopride: a single-dose open-label Phase I study
    Smith, William B.
    Mannaert, Erik
    Verhaeghe, Tom
    Kerstens, Rene
    Vandeplassche, Lieve
    Van de Velde, Vera
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2012, 6 : 407 - 415
  • [39] Open-Label Study To Evaluate the Single-Dose Pharmacokinetics, Safety, and Tolerability of Doripenem in Infants Less than 12 Weeks in Chronological Age
    Cirillo, Iolanda
    Vaccaro, Nicole
    Castaneda-Ruiz, Bibiana
    Redman, Rebecca
    Cossey, Veerle
    Bradley, John S.
    Allegaert, Karel
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (08) : 4742 - 4749
  • [40] A PHASE 1, OPEN-LABEL, SINGLE-DOSE, NON-RANDOMIZED STUDY TO EVALUATE PHARM ACOKIN ETICS AND PHARM ACO DYNAMICS OF EDOXABAN IN PEDIATRIC PATIENTS.
    Zou, P.
    Zahir, H.
    Duggal, A.
    Pandya, G.
    Jin, J.
    Leil, T.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 : S100 - S100